Cwestiwn ysgrifenedig WQ99940
- Gofynnwyd gan
- Cai Parry-JonesReform
- I'w ateb gan
- Cabinet Minister for Health and Care
- Cyflwynwyd
- Dyddiad ateb
- Atebwyd
- Amser i'w ateb
- 13 diwrnod
Cwestiwn
Mae'r cwestiwn a'r ateb yn Saesneg gan nad oes fersiwn Gymraeg ar gael.
What assurances has the Cabinet Minister sought that health boards participating in clinical trials involving multi-system diagnostic imaging have appropriate procedures for identifying, communicating and following up incidental findings?
Ateb
Atebwyd gan Cabinet Minister for Health and Care (Mabon ap Gwynfor)
The Welsh Government expects health boards to deliver clinical trials in line with all ethical, regulatory and governance requirements, including approved arrangements for identifying, communicating and following up incidental findings.
The Health Research Authority oversees governance and ethics review, while the Medicines and Healthcare products Regulatory Agency authorises and regulates clinical trials of medicines. The Medical Research Council is not a regulator but provides guidance on managing health-related findings. Health boards must ensure trials follow the approved protocol and participant safety arrangements.